Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (81-90 of 269) with videos related to

Pageof 27
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2018
Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutationsJennifer Guimbellot, George M Solomon, Arthur Baines, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2018
Seeing cilia: imaging modalities for ciliary motion and clinical connectionsJacelyn E Peabody, Ren-Jay Shei, Brent M Bermingham, et al.
Human Molecular Genetics|June 3, 2017
Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequencesXiaojiao Xue, Venkateshwar Mutyam, Amita Thakerar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 20, 2021
Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry dataGabriela R Oates, Elizabeth Baker, Joseph M Collaco, et al.
JCI Insight|June 17, 2020
Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged miceYan Y Sanders, Xing Lyv, Q Jennifer Zhou, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Pilot evaluation of ivacaftor for chronic bronchitisGeorge M Solomon, Heather Hathorne, Bo Liu, et al.
Respiratory Research|February 13, 2014
Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitisS Vamsee Raju, Jody H Tate, Sandra K G Peacock, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 20, 2022
Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551DJordana E Hoppe, Brandie D Wagner, J Kirk Harris, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 15, 2023
SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung diseaseElex S Harris, Lea Novak, Courtney M Fernandez-Petty, et al.
The European Respiratory Journal|April 1, 2023
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyondMarcus A Mall, Gerard J Criner, Marc Miravitlles, et al.
Pageof 27

Showing results (81-90 of 269) with videos related to

Sort By:
Pageof 27
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2018
Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutationsJennifer Guimbellot, George M Solomon, Arthur Baines, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2018
Seeing cilia: imaging modalities for ciliary motion and clinical connectionsJacelyn E Peabody, Ren-Jay Shei, Brent M Bermingham, et al.
Human Molecular Genetics|June 3, 2017
Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequencesXiaojiao Xue, Venkateshwar Mutyam, Amita Thakerar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 20, 2021
Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry dataGabriela R Oates, Elizabeth Baker, Joseph M Collaco, et al.
JCI Insight|June 17, 2020
Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged miceYan Y Sanders, Xing Lyv, Q Jennifer Zhou, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Pilot evaluation of ivacaftor for chronic bronchitisGeorge M Solomon, Heather Hathorne, Bo Liu, et al.
Respiratory Research|February 13, 2014
Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitisS Vamsee Raju, Jody H Tate, Sandra K G Peacock, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 20, 2022
Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551DJordana E Hoppe, Brandie D Wagner, J Kirk Harris, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 15, 2023
SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung diseaseElex S Harris, Lea Novak, Courtney M Fernandez-Petty, et al.
The European Respiratory Journal|April 1, 2023
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyondMarcus A Mall, Gerard J Criner, Marc Miravitlles, et al.
Pageof 27